Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2022-07-26 00:00:00 ET · period of report 2022-07-22 · accession 0001937412-22-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-26 | 2022-07-22 | CLOV | Edwards Carladenise Armbrister | Dir | A - Grant | $0.00 | +8,805 | 8,805 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-07-22 | A | A | 8,805 | $0.00 | 8,805 | D | — | — | (F1) Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in full on September 22, 2022, the date of the Company's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service as a member of the Board through such vesting date. |